Kelly D. Davis

Kelly D. Davis is a proficient professional with extensive experience in the pharmaceutical industry and medical research. Currently serving as an Independent Consultant since June 2014, Kelly D. Davis also holds the position of Senior Vice President of Medical and Research Services at UBC: An Express Scripts Company, where tenure began in October 2007. Prior roles include Vice President of Safety, Epidemiology & Risk Management at UBC and Vice President and Therapeutic Area Head in Clinical Research and Development at Wyeth Pharmaceuticals from January 1997 to March 2006, specializing in inflammation and metabolism. Kelly D. Davis began an academic career as an Assistant Professor of Medicine at the University of Pennsylvania School of Medicine from 1992 to 1997, focusing on endocrinology, diabetes, and metabolism. Educational qualifications include an M.D. from the University of Pennsylvania School of Medicine (1989-1991), alongside previous studies at Temple University - Lewis Katz School of Medicine (1984-1987) and the University of Kansas Medical Center (1980-1984).